Endoskooppinen kortisoni vaikean juveniilin parotiitin hoidossa

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-003097-97-FI

Enrollment

Registered

2006-06-05

Start date

2009-03-09

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

juveniili parotiitti MedDRA version: 8.1 Level: LLT Classification code 10034038 Term: Parotitis

Interventions

Trade Name: Solu-Cortef Product Name: Solu-Cortef Pharmaceutical Form: Injection* INN or Proposed INN: HYDROCORTISONE SODIUM SUCCINATE CAS Number: 125042 Concentration unit: % percent Concentration ty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lapset, jotka sairastneet 3 tai useamman sylkirauhastulehduksen vuoden aikana Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: juveniilin parotiitin diagnostiikan ja hoidon tason parantaminen;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026